The leadership team at DBV Technologies has experience in the biotech and pharmaceutical industries, as well as in mathematics and biochemistry. The team has held positions at Alcresta Therapeutics, Indivior, Regenxbio, HLS Therapeutics Inc., Bellerophon Therapeutics, and IKARIA.
View all